Cargando…

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries

BACKGROUND: The World Health Organization (WHO) recommends a 2-dose HPV vaccine schedule for girls aged 9–14 years. As randomised controlled trials assessing the immunogenicity and efficacy of a 1-dose schedule are ongoing, we interviewed immunisation programme managers and advisors in low and middl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallagher, Katherine E., Kelly, Helen, Cocks, Naomi, Dixon, Sandra, Mounier-Jack, Sandra, Howard, Natasha, Watson-Jones, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218645/ https://www.ncbi.nlm.nih.gov/pubmed/30352297 http://dx.doi.org/10.1016/j.pvr.2018.10.004

Ejemplares similares

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
por: Kabakama, Severin, et al.
Publicado: (2016)

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
por: Howard, N., et al.
Publicado: (2016)

Co-production of an educational package for the universal human papillomavirus (HPV) vaccination programme tailored for schools with low uptake: a participatory study protocol
por: Fisher, Harriet, et al.
Publicado: (2020)

Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants
por: Fisher, Harriet, et al.
Publicado: (2022)

Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives
por: Yared, Nicholas, et al.
Publicado: (2021)

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
por: Bergman, Hanna, et al.
Publicado: (2019)

Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls’ HPV vaccination programme in England
por: Paterson, P, et al.
Publicado: (2019)

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
por: Guillaume, Dominique, et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()
por: Wigle, Jannah, et al.
Publicado: (2013)

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
por: Tshomo, Ugyen, et al.
Publicado: (2014)

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
por: Ngabo, Fidele, et al.
Publicado: (2016)

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review
por: Deignan, Caroline, et al.
Publicado: (2021)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review
por: Gallagher, K. E., et al.
Publicado: (2016)

Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
por: van Zandvoort, Kevin, et al.
Publicado: (2019)

Stakeholder Perspectives of Australia’s National HPV Vaccination Program
por: Swift, Caitlin, et al.
Publicado: (2022)

Impact of new consent procedures on uptake of the schools-based human papillomavirus (HPV) vaccination programme
por: Fisher, Harriet, et al.
Publicado: (2020)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction ()
por: Li, Anyie J., et al.
Publicado: (2022)

Development of a multicomponent intervention to increase parental vaccine confidence and young people’s access to the universal HPV vaccination programme in England: protocol for a co-design study
por: Fisher, Harriet, et al.
Publicado: (2022)

Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination
por: Wilson, Lindsay A., et al.
Publicado: (2021)

Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service
por: Bell, Sadie, et al.
Publicado: (2020)

Assessment of Acceptability and Determinants of Uptake and Schedule Completion of Human Papillomavirus (HPV) Vaccine by 25 to 45 Years Old Women in Slovenia
por: Mlakar, Jana, et al.
Publicado: (2023)

Human Papillomavirus (HPV) Vaccination Knowledge, Beliefs, and Hesitancy Associated with Stages of Parental Readiness for Adolescent HPV Vaccination: Implications for HPV Vaccination Promotion
por: Jin, Seok Won, et al.
Publicado: (2023)

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
por: Manolescu, Loredana Sabina Cornelia, et al.
Publicado: (2022)

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis
por: Fisher, Harriet, et al.
Publicado: (2022)

A process evaluation of how the routine vaccination programme is implemented at GP practices in England
por: Crocker-Buque, Tim, et al.
Publicado: (2018)

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents
por: Lismidiati, Wiwin, et al.
Publicado: (2021)

NEW COCHRANE REVIEW ASSESSES DIFFERENT HPV VACCINES AND VACCINE SCHEDULES IN ADOLESCENT GIRLS AND BOYS
Publicado: (2019)

Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach
por: Kawana, Kei, et al.
Publicado: (2012)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Using Electronic Reminders to Improve Human Papillomavirus (HPV) Vaccinations among Primary Care Patients
por: Hanley, Kathleen, et al.
Publicado: (2023)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
por: Mroz, Sarah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hu976m2ltt22svodr923frpkjt